DEA Says Rescheduling Appeals Still Stalled Despite New Administrator’s Promises

The federal push to move cannabis to Schedule III is currently stuck in neutral. Despite new leadership at the DEA and early promises from the Trump administration to expedite a decision, the latest legal filings show the rescheduling appeal process is still idling without a set schedule. DEA Administrator Terrance Cole, who previously told senators this would be a top priority, has yet to signal a concrete breakthrough, leaving the industry and advocates in a familiar state of "wait and see."

While bureaucratic delays are nothing new for the cannabis community, this update is a bit of a buzzkill for those hoping for swift federal reform. For regular tokers, rescheduling is a critical "first domino" that could eventually lead to better banking access, lower prices, and a more legitimate national marketplace. Even if the current political gears are turning slowly, the fact that major GOP figures now view reform as a bipartisan "game changer" suggests the momentum is still there—it’s just caught in some serious red tape for now.